CELADON PHARMACEUTICALS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.5 GBX | -5.13% |
|
-9.76% | -19.57% |
| 14/05 | Headlam warns of loss; EnSilica predicts revenue rise | AN |
| 14/05 | Celadon Pharmaceuticals Plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 79.54M | - | - | - | - | - | |
| 693B | ||||||
| 584B | ||||||
| 372B | ||||||
| 332B | ||||||
| 294B |
